These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 32495499)

  • 1. Successful treatment of pulmonary inflammatory myofibroblastic tumor with platinum-pemetrexed: The first report of two cases.
    Si X; Wang H; Zhang X; Wang M; You Y; Zhang L
    Thorac Cancer; 2020 Aug; 11(8):2339-2342. PubMed ID: 32495499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Practice Patterns and Outcomes for Pemetrexed Plus Platinum Doublet as Neoadjuvant Chemotherapy in Adenocarcinomas of Lung: Looking Beyond the Usual Paradigm.
    Noronha V; Zanwar S; Joshi A; Patil VM; Mahajan A; Janu A; Agarwal JP; Bhargava P; Kapoor A; Prabhash K
    Clin Oncol (R Coll Radiol); 2018 Jan; 30(1):23-29. PubMed ID: 29239731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Updated Analysis From KEYNOTE-189: Pembrolizumab or Placebo Plus Pemetrexed and Platinum for Previously Untreated Metastatic Nonsquamous Non-Small-Cell Lung Cancer.
    Gadgeel S; Rodríguez-Abreu D; Speranza G; Esteban E; Felip E; Dómine M; Hui R; Hochmair MJ; Clingan P; Powell SF; Cheng SY; Bischoff HG; Peled N; Grossi F; Jennens RR; Reck M; Garon EB; Novello S; Rubio-Viqueira B; Boyer M; Kurata T; Gray JE; Yang J; Bas T; Pietanza MC; Garassino MC
    J Clin Oncol; 2020 May; 38(14):1505-1517. PubMed ID: 32150489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pemetrexed Singlet Versus Nonpemetrexed-Based Platinum Doublet as Second-Line Chemotherapy after First-Line Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor Failure in Non-small Cell Lung Cancer Patients with EGFR Mutations.
    Park S; Keam B; Kim SH; Kim KH; Kim YJ; Kim JS; Kim TM; Lee SH; Kim DW; Lee JS; Heo DS
    Cancer Res Treat; 2015 Oct; 47(4):630-7. PubMed ID: 25687850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pneumonectomy-Sparing NSAID Therapy for Pulmonary Inflammatory Myofibroblastic Tumor.
    Ghani S; Desai A; Pokharel S; Demmy T; Dy GK
    J Thorac Oncol; 2015 Sep; 10(9):e89-e90. PubMed ID: 26291018
    [No Abstract]   [Full Text] [Related]  

  • 6. Anaplastic lymphoma kinase-negative pulmonary inflammatory myofibroblastic tumor with multiple metastases and its treatment by Apatinib: A case report.
    Liu Q; Wei J; Liu X; Wang J
    Medicine (Baltimore); 2019 Dec; 98(52):e18414. PubMed ID: 31876714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mass spectrometry-based serum peptidome profiling accurately and reliably predicts outcomes of pemetrexed plus platinum chemotherapy in patients with advanced lung adenocarcinoma.
    Wang L; Tang C; Xu B; Yang L; Qu L; Li L; Li X; Wang W; Qin H; Gao H; He K; Liu X
    PLoS One; 2017; 12(6):e0179000. PubMed ID: 28594947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcomes to pemetrexed-based versus non-pemetrexed-based platinum doublets in patients with KRAS-mutant advanced non-squamous non-small cell lung cancer.
    Ricciuti B; Brambilla M; Cortellini A; De Giglio A; Ficorella C; Sidoni A; Bellezza G; Crinò L; Ludovini V; Baglivo S; Metro G; Chiari R
    Clin Transl Oncol; 2020 May; 22(5):708-716. PubMed ID: 31332704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammatory myofibroblastic tumor involving lung and brain in a 10-year-old boy: a case report.
    Sharma S; Sankhyan N; Kalra V; Garg A; Gupta SD; Agarwala S; Das P
    J Child Neurol; 2009 Oct; 24(10):1302-6. PubMed ID: 19805826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bilateral multiple inflammatory myofibroblastic tumors of the lung successfully treated with corticosteroids.
    Lee MH; Lee HB; Lee YC; Rhee YK; Lee EJ; Chung MJ; Jin GY; Kweon EY; Park SJ
    Lung; 2011 Oct; 189(5):433-5. PubMed ID: 21809057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anlotinib or platinum-pemetrexed as second-line therapy in EGFR T790M-negative lung cancer.
    Zhong RB; Xu JL; Lou YQ; Chu TQ; Zhong H; Han BH
    Ann Palliat Med; 2020 Jul; 9(4):1681-1687. PubMed ID: 32575999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Association between the HER2 Gene Status and the Efficacy of First-line Pemetrexed Combined with Platinum Chemotherapy in Patients with Advanced Lung 
Adenocarcinoma].
    Li P; Li B; Shi Y; Zhang F; Shen S; Li X
    Zhongguo Fei Ai Za Zhi; 2019 Mar; 22(3):137-142. PubMed ID: 30909992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammatory myofibroblastic tumor of the lung: recurrence after steroid treatment.
    Schaeffer CJ; Minai OA; Sharma N; Kanne JP; Mohammed TL
    J Thorac Imaging; 2008 Aug; 23(3):191-3. PubMed ID: 18728547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uterine metastases originating from a pulmonary inflammatory myofibroblastic tumor.
    Zhang J; Li Y; Lou L
    J Cancer Res Ther; 2018; 14(Supplement):S257-S259. PubMed ID: 29578184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Case of an Inflammatory Myofibroblastic Tumor of the Duodenum].
    Park SG; Kim GH; Park HJ; Kahng DH; Lee BE; Park DY
    Korean J Gastroenterol; 2018 Jul; 72(1):28-32. PubMed ID: 30049175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of Platinum/Pemetrexed Combination Chemotherapy in ALK-Positive NSCLC Refractory to Second-Generation ALK Inhibitors.
    Lin JJ; Schoenfeld AJ; Zhu VW; Yeap BY; Chin E; Rooney M; Plodkowski AJ; Digumarthy SR; Dagogo-Jack I; Gainor JF; Ou SI; Riely GJ; Shaw AT
    J Thorac Oncol; 2020 Feb; 15(2):258-265. PubMed ID: 31669591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful treatment of an unresectable inflammatory myofibroblastic tumor of the frontal bone using a cyclooxygenase-2 inhibitor and methotrexate.
    Kusunoki-Nakamoto F; Matsukawa T; Tanaka M; Miyagawa T; Yamamoto T; Shimizu J; Ikemura M; Shibahara J; Tsuji S
    Intern Med; 2013; 52(5):623-8. PubMed ID: 23448776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood mRNA expression of REV3L and TYMS as potential predictive biomarkers from platinum-based chemotherapy plus pemetrexed in non-small cell lung cancer patients.
    Agulló-Ortuño MT; García-Ruiz I; Díaz-García CV; Enguita AB; Pardo-Marqués V; Prieto-García E; Ponce S; Iglesias L; Zugazagoitia J; López-Martín JA; Paz-Ares L; Nuñez JA
    Cancer Chemother Pharmacol; 2020 Mar; 85(3):525-535. PubMed ID: 31832811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory Myofibroblastic Tumor of the Tongue. Report of a Pediatric Case and Review of the Literature.
    Caporalini C; Moscardi S; Tamburini A; Pierossi N; Di Maurizio M; Buccoliero AM
    Fetal Pediatr Pathol; 2018 Apr; 37(2):117-125. PubMed ID: 29336647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Customized Adjuvant Chemotherapy Based on Biomarker Examination May Improve Survival of Patients Completely Resected for Non-small-cell Lung Cancer.
    Liu D; Nakashima N; Nakano J; Tarumi S; Matsuura N; Nakano T; Nii K; Tokunaga Y; Go T; Yokomise H
    Anticancer Res; 2017 May; 37(5):2501-2507. PubMed ID: 28476819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.